DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

The Headache Inducing Effects of Cilostazol on Migraine Patients

Information source: Danish Headache Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Migraine

Intervention: Cilostazol (Drug); Placebo (Drug)

Phase: N/A

Status: Completed

Sponsored by: Danish Headache Center


We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.

Clinical Details

Official title: The Headache Inducing Effects of Cilostazol on Migraine Patients

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research

Primary outcome: The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.


Minimum age: 18 Years. Maximum age: 60 Years. Gender(s): Both.


Inclusion Criteria:

- Diagnosed with migraine without aura according to the IHS criteria from 2004.

- Healthy besides migraine

Exclusion Criteria:

- Tension-type headache more than 3 days per month

- Other types of primary headaches

- Pregnancy

- History of vascular diseases or psychiatric diseases.

Locations and Contacts

Danish Headache Center & Department of Neurology, Copenhagen, Glostrup 2600, Denmark
Additional Information

Starting date: April 2013
Last updated: June 5, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017